NEW YORK, Nov. 1 (GenomeWeb News) - DNAPrint Genomics acquired privately held Kenna Technologies in an all-stock transaction, DNAPrint said today.
Shareholders of the West Chester, PA-based company exchanged all of their outstanding shares for 1.5 million shares of DNAPrint's common stock. The transaction took effect Oct. 25.
With the acquisition, DNAPRint gains Kenna's BoneFusion and CellCycleFusion models. BoneFusion simulates processes in bone remodeling and CellCycleFusion simulates molecular pathways that control basic cellular functions.